Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.

CEO

Christophe Weber

CEOChristophe Weber

Employees

47,455

Employees47,455

Headquarters

Osaka, Osaka

HeadquartersOsaka, Osaka

Founded

1781

Founded1781

Employees

47,455

Employees47,455

TAK Key Statistics

Market cap

51.56B

Market cap51.56B

Price-Earnings ratio

194.19

Price-Earnings ratio194.19

Dividend yield

3.65%

Dividend yield3.65%

Average volume

1.78M

Average volume1.78M

High today

$16.38

High today$16.38

Low today

$16.06

Low today$16.06

Open price

$16.29

Open price$16.29

Volume

3.04M

Volume3.04M

52 Week high

$16.42

52 Week high$16.42

52 Week low

$12.80

52 Week low$12.80

TAK News

TipRanks 1d

Halozyme announces global collaboration, license agreement with Takeda

Halozyme Therapeutics (HALO) announced the company entered into a global collaboration and exclusive license agreement with Takeda (TAK) in December 2025. The a...

TipRanks 5d

Takeda, Protagonist Therapeutics submit rusfertide new drug application to FDA

Takeda (TAK) and Protagonist Therapeutics (PTGX) announced the submission of a new drug application to the FDA seeking approval of rusfertide for the treatment...

Analyst ratings

58%

of 12 ratings

Buy

41.7%

Hold

58.3%

Sell